Aytu BioPharma Inc. (AYTU)
NASDAQ · Healthcare
Aytu BioPharma Inc. EBITDA 2014–2025
Aytu BioPharma Inc. annual/quarterly ebitda history and growth rate from 2014 to 2025. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Aytu BioPharma Inc. ebitda for the quarter ending September 30, 2025 was -701000, a 273.51% decrease year-over-year.
- Aytu BioPharma Inc. ebitda for the twelve months ending September 30, 2025 was 5.0 M, a 150.49% decrease year-over-year.
- Aytu BioPharma Inc. annual ebitda for 2025 was -2.5 M, a 136.67% decrease from 2024.
- Aytu BioPharma Inc. annual ebitda for 2024 was 6.7 M, a 180.98% decrease from 2023.
- Aytu BioPharma Inc. annual ebitda for 2023 was -8.3 M, a 91.73% decrease from 2022.
- Aytu BioPharma Inc. annual ebitda for 2022 was -99.8 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Aytu BioPharma Inc. EBITDA — FAQ
Aytu BioPharma Inc. (AYTU) ebitda over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AYTU's ebitda history?
The chart and table above show Aytu BioPharma Inc.'s ebitda by year and by quarter, including the growth rate.